DIA Master Relative Effectiveness Assessment Training CourseMet Korting
The course will cover key concepts and provide an overview of methods used in the assessment and appraisal of pharmaceuticals during the pricing and reimbursement (funding) decision-making process.
The course will reflect on market access and HTA and it will illustrate how pharmaceutical pricing & reimbursement policy is developing, how the use of HTA is evolving, and how companies should address these developments by reinforcing both their strategic and technical market access capabilities. The course will cover key concepts and provide an overview of methods used in the assessment and appraisal of pharmaceuticals during the pricing and reimbursement (funding) decision-making process. The training session will consist of trainer presentations followed by interactive discussions and case studies. The interactive sessions will allow participants to reinforce their skills to interpret HTA reports and results and to formulate successful local value propositions.
The course is aimed at professionals with limited/no technical experience of HTA who may face market access challenges and opportunities on a daily basis. The course will be of interest to participants from the pharmaceutical industry working in the field of:
- Market Access
- Government and Public Affairs
- Health Economics & Outcome Research
- Patient Advocacy
- Drug Development
- Regulatory Affairs
- Medical Affairs
HollandBIO members are eligible for a 15% discount. To obtain the discount please send your registration form to: email@example.com